UBS Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34B | Sell |
|
|||||
|
2025
Q1 | $1.89B | Buy |
|
|||||
|
2024
Q4 | $1.72B | Buy |
|
|||||
|
2024
Q3 | $1.74B | Buy |
|
|||||
|
2024
Q2 | $1.8B | Buy |
|
|||||
|
2024
Q1 | $1.79B | Buy |
|
|||||
|
2023
Q4 | $1.38B | Buy |
|
|||||
|
2023
Q3 | $1.26B | Sell |
|
|||||
|
2023
Q2 | $1.47B | Sell |
|
|||||
|
2023
Q1 | $1.36B | Buy |
|
|||||
|
2022
Q4 | $1.41B | Buy |
|
|||||
|
2022
Q3 | $945M | Sell |
|
|||||
|
2022
Q2 | $1.08B | Sell |
|
|||||
|
2022
Q1 | $992M | Sell |
|
|||||
|
2021
Q4 | $997M | Buy |
|
|||||
|
2021
Q3 | $950M | Buy |
|
|||||
|
2021
Q2 | $838M | Buy |
|
|||||
|
2021
Q1 | $720M | Sell |
|
|||||
|
2020
Q4 | $777M | Sell |
|
|||||
|
2020
Q3 | $931M | Buy |
|
|||||
|
2020
Q2 | $836M | Buy |
|
|||||
|
2020
Q1 | $805M | Sell |
|
|||||
|
2019
Q4 | $1.19B | Buy |
|
|||||
|
2019
Q3 | $994M | Buy |
|
|||||
|
2019
Q2 | $985M | Buy |
|
|||||
|
2019
Q1 | $760M | Buy |
|
|||||
|
2018
Q4 | $687M | Sell |
|
|||||
|
2018
Q3 | $802M | Buy |
|
|||||
|
2018
Q2 | $684M | Buy |
|
|||||
|
2018
Q1 | $588M | Sell |
|
|||||
|
2017
Q4 | $608M | Buy |
|
|||||
|
2017
Q3 | $638M | Sell |
|
|||||
|
2017
Q2 | $639M | Buy |
|
|||||
|
2017
Q1 | $628M | Buy |
|
|||||
|
2016
Q4 | $551M | Buy |
|
|||||
|
2016
Q3 | $542M | Sell |
|
|||||
|
2016
Q2 | $568M | Buy |
|
|||||
|
2016
Q1 | $510M | Sell |
|
|||||
|
2015
Q4 | $563M | Buy |
|
|||||
|
2015
Q3 | $519M | Buy |
|
|||||
|
2015
Q2 | $581M | Sell |
|
|||||
|
2015
Q1 | $635M | Sell |
|
|||||
|
2014
Q4 | $679M | Buy |
|